<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Peter Firestein &#187; Pfizer</title>
	<atom:link href="http://www.peterfiresteinblog.com/tag/pfizer/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.peterfiresteinblog.com</link>
	<description>CORPORATION, REPUTATION, AND SOCIETY</description>
	<lastBuildDate>Wed, 21 Dec 2011 19:30:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Why Do Pharma Abuses Persist? It&#8217;s the Business Model, Stupid.</title>
		<link>http://www.peterfiresteinblog.com/2010/01/17/why-do-pharma-abuses-persist-its-the-business-model-stupid/</link>
		<comments>http://www.peterfiresteinblog.com/2010/01/17/why-do-pharma-abuses-persist-its-the-business-model-stupid/#comments</comments>
		<pubDate>Sun, 17 Jan 2010 16:14:40 +0000</pubDate>
		<dc:creator>Peter Firestein</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Bextra]]></category>
		<category><![CDATA[Corporate Reputation]]></category>
		<category><![CDATA[David Brennan]]></category>
		<category><![CDATA[drug companies]]></category>
		<category><![CDATA[Eli Lilly]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[Seroquel]]></category>
		<category><![CDATA[Vioxx]]></category>
		<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.peterfiresteinblog.com/?p=140</guid>
		<description><![CDATA[Pharmaceutical group AstraZeneca recently reached agreement with the U.S. government to pay over half a billion dollars for its improper marketing of schizophrenia drug, Seroquel. CEO David Brennan told the Wall St. Journal that off-label marketing (the effort to sell drugs for unapproved uses) “is a much bigger issue in the last few years as [...]]]></description>
		<wfw:commentRss>http://www.peterfiresteinblog.com/2010/01/17/why-do-pharma-abuses-persist-its-the-business-model-stupid/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

